Cheltenham General Hospital is an NHS district general hospital in Cheltenham, Gloucestershire, run by Gloucestershire Hospitals NHS Foundation Trust. It provides general hospital services including Accident and Emergency.

During the past decade, Cheltenham General Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 7 clinical trials were completed, i.e. on average, 31.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cheltenham General Hospital" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 7 trials, followed by "Institute of Cancer Research, United Kingdom" with 6 trials sponsored, "Medical Research Council" with 4 trials sponsored, "University College, London" with 4 trials sponsored and "Coloplast A/S" with 4 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cheltenham General Hospital" #1 collaborator was "Cancer Research UK" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator and "BUPA Foundation" with 1 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Cheltenham General Hospital" are "Breast Cancer" (12 trials), "Bladder Cancer" (4 trials), "Lymphoma" (4 trials), "Ovarian Cancer" (3 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Cheltenham General Hospital" in a lesser frequency.

Most popular intervention types in "Cheltenham General Hospital" are "Drug" (35 trials), "Procedure" (13 trials), "Radiation" (13 trials), "Biological" (10 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (7 trials), "radiation therapy" (6 trials), "adjuvant therapy" (5 trials), "fluorouracil" (5 trials) and "Cisplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Cheltenham General Hospital" are 38 trials for "All" genders, 13 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Cheltenham General Hospital". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Cheltenham General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cheltenham General Hospital, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".